2017, Number 1
Factores de riesgo de mortalidad en pacientes con neumonía adquirida en la comunidad
Language: Spanish
References: 10
Page: 21-29
PDF size: 287.51 Kb.
ABSTRACT
Introduction: the acquired pneumonia in the community is defined as an inflammation of the lung parenchyma by an infectious agent. Objective: to determine the potential risk factors of mortality of different variables. Method: an analytical study was realized of such cases and controls in patients admitted in the Room of Internal Medicine at “Celestino Hernández Robau” Hospital with diagnosis of acquired pneumonia in the community in the period from January to December 2015. Results: the leukopenia and the hypotension detected at admission and ages 60 and older and prolonged bed rest behaved as the most common risk factors associated with mortality. Chronic obstructive pulmonary disease, history of cerebrovascular disease and the presence of neoplasms represent a fourfold increased risk as predictors. Conclusions: other variables such as submitting pneumonia in a shorter period of time than a year, history of ischemic heart disease, heart failure, alcoholism, chronic steroid use, diabetes mellitus, liver cirrhosis, smoking and presence of pleural effusion associated to an increased risk of mortality in relation to the control group, although to a lesser extent than before.REFERENCES
Pérez Cala AE, Viamontes Tapia MN, Benítez Sánchez E, Chang Fong A, Guerra Cepena E. Aplicabilidad clínica del índice de Fine en pacientes con neumonía adquirida en la comunidad. Medisan [Internet]. 2013 [citado 18 Mar2014];17(4):605-616. Disponible en: http://scielo.sld.cu/pdf/san/v17n4/san07413.pdf
Carpio-Deheza G, Céspedes-Vargas J. Neumonía adquirida en la comunidad: estudio inicial de validación de una escala pronóstica para su empleo en emergencias del Hospital Clínico Viedma. Rev Méd-Cient “Luz vida” [Internet]. 2013 [citado 18 Mar 2014];4(1):17-23.Disponible en: https://dialnet.unirioja.es/descarga/articulo/4699718.pdf
López Véjar CE, Castellanos de la Cruz L, Meraz Ortega R, Román Flores A, Geuguer Chávez L, Pedro González A, et al. Eficacia del levofloxacino en el tratamiento de neumonía adquirida en la comunidad. Med Int Mex [Internet]. 2013 [citado 18 Mar 2014];29(6):587-594. Disponible en: http://www.imbiomed.com/1/1/articulos.php?method=showDetail&id_revista=47&id_seccion=1479&id_ejemplar=9585&id_articulo=98140
Díaz Baquero A, Álvarez Gutiérrez FJ, Romero Falcón A, Medina Gallardo JF. Protocolo de tratamiento empírico de las neumonías adquiridas en la comunidad. Medicine [Internet]. 2010 [citado 18 Mar 2014];10(67):[aprox. 3 p.]. Disponible en: http://anothersample.net/protocolo-de-tratamiento-empirico-de-las-neumonias-adquiridas-en-la-comunidad
Menéndez R, Torres A, Aspa J, Capelastegui A, Prat C, Rodríguez de Castro F. Neumonía adquirida en la comunidad. Nueva normativa de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Arch Bronconeumol [Internet]. 2010 [citado 18 Mar2014];46(10):543-58. Disponible en: http://www.archbronconeumol.org/es/neumonia-adquirida-comunidad-nueva-normativa/articulo/S0300289610002000/